Insights

Leadership in Vaccine Research The Duke Human Vaccine Institute is a recognized leader in global infectious disease research, actively developing vaccines for HIV, influenza, SARS-CoV-2, and other pathogens. This leadership position offers opportunities for collaboration in advanced vaccine technologies and custom therapeutics development.

Innovative AI Advancements Duke has recently developed an AI framework capable of uncovering simple rules within complex natural and technological systems. This technological innovation signals openness to advanced data analytics, machine learning solutions, and AI-powered research tools that could enhance their research capabilities.

Funding and Revenue Potential With revenues estimated between $50 million to $100 million, Duke’s expanding research activities represent a substantial market for high-tech research tools, lab equipment, data management solutions, and specialized software tailored to biotech and pharmaceutical research.

Strong Academic Network Duke actively participates in industry events, leadership forums, and collaborative projects such as carbon credits initiatives, highlighting a broad network of academic and industry partnerships. These connections provide strategic entry points for technology providers and research service collaborations.

Focus on Emerging Technologies Beyond vaccine development, Duke’s investments in biodefense, emerging infections, and digital strategies demonstrate an openness to innovative solutions such as advanced lab instrumentation, cybersecurity, and digital infrastructure to support cutting-edge research missions.

The Duke Human Vaccine Institute Tech Stack

The Duke Human Vaccine Institute uses 8 technology products and services including Microsoft Advertising, Renderforest, DreamWeaver, and more. Explore The Duke Human Vaccine Institute's tech stack below.

  • Microsoft Advertising
    Advertising
  • Renderforest
    Editors
  • DreamWeaver
    Editors
  • OnBase
    Enterprise Content Management
  • Netid
    Governance, Risk And Compliance
  • reCAPTCHA
    Security
  • LabVIEW
    Visualisation Software
  • AddToAny
    Widgets

Media & News

The Duke Human Vaccine Institute's Email Address Formats

The Duke Human Vaccine Institute uses at least 2 format(s):
The Duke Human Vaccine Institute Email FormatsExamplePercentage
First.Last@duke.eduJohn.Doe@duke.edu
77%
FLast@duke.eduJDoe@duke.edu
12%
FirstLast@duke.eduJohnDoe@duke.edu
4%
FL@duke.eduJD@duke.edu
2%
F.Last@duke.eduJ.Doe@duke.edu
1%
Last@duke.eduDoe@duke.edu
1%
First@duke.eduJohn@duke.edu
1%
FirLast@duke.eduJohDoe@duke.edu
1%
Fir.Last@duke.eduJoh.Doe@duke.edu
1%
First.Last@dhvi.duke.eduJohn.Doe@dhvi.duke.edu
100%

Frequently Asked Questions

Where is The Duke Human Vaccine Institute's headquarters located?

Minus sign iconPlus sign icon
The Duke Human Vaccine Institute's main headquarters is located at 2 Genome Court Durham, North Carolina 27710 United States. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is The Duke Human Vaccine Institute's official website and social media links?

Minus sign iconPlus sign icon
The Duke Human Vaccine Institute's official website is dhvi.duke.edu and has social profiles on LinkedIn.

What is The Duke Human Vaccine Institute's NAICS code?

Minus sign iconPlus sign icon
The Duke Human Vaccine Institute's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does The Duke Human Vaccine Institute have currently?

Minus sign iconPlus sign icon
As of March 2026, The Duke Human Vaccine Institute has approximately 196 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Of Staff: K. C.Chief Of Staff: K. C.Founder And Ceo: P. F.. Explore The Duke Human Vaccine Institute's employee directory with LeadIQ.

What industry does The Duke Human Vaccine Institute belong to?

Minus sign iconPlus sign icon
The Duke Human Vaccine Institute operates in the Research Services industry.

What technology does The Duke Human Vaccine Institute use?

Minus sign iconPlus sign icon
The Duke Human Vaccine Institute's tech stack includes Microsoft AdvertisingRenderforestDreamWeaverOnBaseNetidreCAPTCHALabVIEWAddToAny.

What is The Duke Human Vaccine Institute's email format?

Minus sign iconPlus sign icon
The Duke Human Vaccine Institute's email format typically follows the pattern of First.Last@duke.edu. Find more The Duke Human Vaccine Institute email formats with LeadIQ.

When was The Duke Human Vaccine Institute founded?

Minus sign iconPlus sign icon
The Duke Human Vaccine Institute was founded in 1990.

The Duke Human Vaccine Institute

Research ServicesNorth Carolina, United States51-200 Employees

The Duke Human Vaccine Institute (DHVI) has established a place of national and international leadership in the fight against major infectious diseases. DHVI plays an integral leadership role in the Global HIV/AIDS Vaccine Enterprise and is a pioneer in emerging infections and biodefense research. By focusing on the scientific “bottlenecks” for the development of HIV, influenza, SARS-CoV-2, and other vaccines and therapeutics, DHVI investigators continue to make significant contributions to overcome global health challenges on behalf of society.

Our Mission:
To develop vaccines and therapeutics against diseases of global importance while training the next generation of scientists.

Our Values: The DHVI supports the development of vaccines and therapeutics through a commitment to Innovation, Collaboration, and Excellence.

Excellence through a commitment to respect, integrity, and safety
Collaboration through embracing change and cultivating diversity to achieve synergy
Innovation through ingenuity and the pursuit of continuous improvement

Section iconCompany Overview

Headquarters
2 Genome Court Durham, North Carolina 27710 United States
NAICS Code
5417 - Scientific Research and Development Services
Founded
1990
Employees
51-200

Section iconFunding & Financials

  • $50M$100M

    The Duke Human Vaccine Institute's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    The Duke Human Vaccine Institute's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.